Plymouth University researchers in first ever UK brain tumor workshop

June 10, 2015

In an exciting step forward to finding a cure for brain tumours, which kill more children and adults under the age of 40 than any other cancer, the national charity Brain Tumour Research brought together a group of leading brain tumour scientists and clinicians to help accelerate vital research into this devastating disease.

A dozen researchers drawn from across the charity's four Research Centres of Excellence - Imperial College Healthcare NHS Trust, Plymouth University, Queen Mary University of London (in partnership with UCL in London) and the University of Portsmouth - met at Lydiard House conference venue in Swindon at the end of May to each present the latest developments from their respective research programmes.

This ground-breaking workshop - the first of its kind in the UK organised by a brain tumour charity - was aimed at fostering pro-active partnerships between key research hubs. Sharing their insights, the team looked at developments in research for low and high-grade brain tumours, adult and paediatric brain tumours, and multi-pronged targeting of brain tumours by attacking mitochondria that control cancer cell growth and killing the stem cells that produce new cancer cells. Surgical advances were also revealed, including updates on the iKnife - a smart scalpel that can 'sniff out' cancer cells during surgery and provide real-time diagnostic information about the type of brain tumour being operated on.

The scientists identified some distinct areas of prospective collaboration and interaction between the four centres to speed up the process of research translation from laboratory into clinical trials in order to provide better outcomes for brain tumour patients in future and to one day find a cure. These included developing new initiatives and procedures around biobanking, obtaining and sharing brain tumour tissue samples, equipment sharing, pathology support, and imaging technology. Everyone recognised the need for greater funding to fast-track research translation from laboratory to clinic and to combine efforts to combat glioblastoma multiforme (GBM), the most common and deadly form of brain tumour with very low survival rates.

Professor Geoff Pilkington, from the charity's first research Centre of Excellence based at the University of Portsmouth, said:

"This funding stream is enabling us to look at so many diverse areas of research. Repurposing drugs, new drug delivery systems, paediatric neuro-oncology, cancer metastases, the brain tumour micro-environment and a mitochondrial and metabolic approach to brain tumours.

Professor Oliver Hanemann, Associate Dean Research at Plymouth University Peninsula Schools of Medicine and Dentistry and lead research for brain tumours at Plymouth, added:

"This workshop was a strong step forward for our research. There was a lot of challenging debate among the team about what we wanted to prioritise in future collaborations. Having Brain Tumour Research facilitate this kind of workshop meant that we were challenged to really identify the best areas of research where we felt we could advance and maximise results together."

Sue Farrington Smith, Chief Executive of Brain Tumour Research said:

"We now have four flourishing Brain Tumour Research Centres in the UK, which means we are able to build on specialist brain tumour expertise and experience and encourage cross-pollination of the very best thinking at the cutting edge of brain tumour research. Our ultimate vision is to find a cure for brain tumours through acceleration of research into this most devastating of diseases. Brain tumours kill more children and adults under the age of 40 than any other cancer... Yet just one per cent of the national spend on cancer research is allocated to this devastating disease. This is unacceptable! We are striving to fund a network of seven dedicated research centres whilst challenging the government and larger cancer charities to invest more in brain tumour research. Help us fund the fight. Together we will find a cure."

University of Plymouth

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to